• +1-646-491-9876
    • +91-20-67278686

    Search

    Colorectal Cancer Pipeline Review H1 2017

    Colorectal Cancer Pipeline Review H1 2017

    • Report Code ID: RW0001866804
    • Category Pharmaceuticals
    • No. of Pages 1799
    • Publication Month Jun-17
    • Publisher Name Global Markets Direct
    Colorectal Cancer - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts in the large intestine (colon) . There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 1, 25, 108, 137, 10, 173, 26 and 10 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 18, 9, 28 and 5 molecules, respectively.

    Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology) .
    - The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    Introduction 11
    Colorectal Cancer - Overview 12
    Colorectal Cancer - Therapeutics Development 13
    Colorectal Cancer - Therapeutics Assessment 66
    Colorectal Cancer - Companies Involved in Therapeutics Development 94
    Colorectal Cancer - Drug Profiles 223
    Colorectal Cancer - Dormant Projects 1708
    Colorectal Cancer - Discontinued Products 1725
    Colorectal Cancer - Product Development Milestones 1730
    Appendix 1745

    List of Tables

    Number of Products under Development for Colorectal Cancer, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..9) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..10) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..11) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..12) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..13) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..14) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..15) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..16) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..4) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..5) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..6) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..7) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..8) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..9) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..10) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..11) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..12) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..13) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..14) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..15) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..16) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..17) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..18) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..19) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..20) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..21) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..22) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..23) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..24) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..25) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..1) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..2) , H1 2017
    Products under Development by Universities/Institutes, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..4) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..5) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..6) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..7) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..8) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..9) , H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..10) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..4) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..5) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..6) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..7) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..8) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..9) , H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..10) , H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Colorectal Cancer - Pipeline by 2cureX ApS, H1 2017
    Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by 3SBio Inc, H1 2017
    Colorectal Cancer - Pipeline by 4SC AG, H1 2017
    Colorectal Cancer - Pipeline by AB Science SA, H1 2017
    Colorectal Cancer - Pipeline by AbbVie Inc, H1 2017
    Colorectal Cancer - Pipeline by AbGenomics International Inc, H1 2017
    Colorectal Cancer - Pipeline by Adamed Sp z oo, H1 2017
    Colorectal Cancer - Pipeline by Aduro BioTech Inc, H1 2017
    Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H1 2017
    Colorectal Cancer - Pipeline by Alchemia Ltd, H1 2017
    Colorectal Cancer - Pipeline by Allinky Biopharma, H1 2017
    Colorectal Cancer - Pipeline by amcure GmbH, H1 2017
    Colorectal Cancer - Pipeline by Amgen Inc, H1 2017
    Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by APEIRON Biologics AG, H1 2017
    Colorectal Cancer - Pipeline by Apexigen Inc, H1 2017
    Colorectal Cancer - Pipeline by Aphios Corp, H1 2017
    Colorectal Cancer - Pipeline by Aposense Ltd, H1 2017
    Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by ArQule Inc, H1 2017
    Colorectal Cancer - Pipeline by Array BioPharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Asana BioSciences LLC, H1 2017
    Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2017
    Colorectal Cancer - Pipeline by Astellas Pharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by AstraZeneca Plc, H1 2017
    Colorectal Cancer - Pipeline by Aurobindo Pharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by B Cell Design SAS, H1 2017
    Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H1 2017
    Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H1 2017
    Colorectal Cancer - Pipeline by Bayer AG, H1 2017
    Colorectal Cancer - Pipeline by BeiGene (Beijing) Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Biocon Ltd, H1 2017
    Colorectal Cancer - Pipeline by Bionomics Ltd, H1 2017
    Colorectal Cancer - Pipeline by Bionovis SA, H1 2017
    Colorectal Cancer - Pipeline by Biotecnol Ltd, H1 2017
    Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H1 2017
    Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2017
    Colorectal Cancer - Pipeline by Boston Biomedical Inc, H1 2017
    Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H1 2017
    Colorectal Cancer - Pipeline by Burzynski Research Institute Inc, H1 2017
    Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Carna Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H1 2017
    Colorectal Cancer - Pipeline by Celgene Corp, H1 2017
    Colorectal Cancer - Pipeline by Celldex Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Cellectar Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Celleron Therapeutics Ltd, H1 2017
    Colorectal Cancer - Pipeline by Celltrion Inc, H1 2017
    Colorectal Cancer - Pipeline by Celyad SA, H1 2017
    Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H1 2017
    Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2017
    Colorectal Cancer - Pipeline by Cipla Ltd, H1 2017
    Colorectal Cancer - Pipeline by Cleave Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Cleveland BioLabs Inc, H1 2017
    Colorectal Cancer - Pipeline by COARE Biotechnology Inc, H1 2017
    Colorectal Cancer - Pipeline by Coherus BioSciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Compugen Ltd, H1 2017
    Colorectal Cancer - Pipeline by Conatus Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Confluence Life Sciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc, H1 2017
    Colorectal Cancer - Pipeline by CrystalGenomics Inc, H1 2017
    Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd, H1 2017
    Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H1 2017
    Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC, H1 2017
    Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H1 2017
    Colorectal Cancer - Pipeline by Eisai Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Eli Lilly and Company, H1 2017
    Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H1 2017
    Colorectal Cancer - Pipeline by EnGeneIC Ltd, H1 2017
    Colorectal Cancer - Pipeline by Ensol Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by EntreChem SL, H1 2017
    Colorectal Cancer - Pipeline by Enzene Biosciences Ltd, H1 2017
    Colorectal Cancer - Pipeline by Enzo Biochem Inc, H1 2017
    Colorectal Cancer - Pipeline by EpiThany Inc, H1 2017
    Colorectal Cancer - Pipeline by Etubics Corp, H1 2017
    Colorectal Cancer - Pipeline by Exelixis Inc, H1 2017
    Colorectal Cancer - Pipeline by Exicure Inc, H1 2017
    Colorectal Cancer - Pipeline by F-star Biotechnology Ltd, H1 2017
    Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017
    Colorectal Cancer - Pipeline by Formosa Laboratories Inc, H1 2017
    Colorectal Cancer - Pipeline by Forty Seven Inc, H1 2017
    Colorectal Cancer - Pipeline by Fusion Antibodies Ltd, H1 2017
    Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Genentech Inc, H1 2017
    Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Genoscience Pharma, H1 2017
    Colorectal Cancer - Pipeline by Genzyme Corp, H1 2017
    Colorectal Cancer - Pipeline by Gilead Sciences Inc, H1 2017
    Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H1 2017
    Colorectal Cancer - Pipeline by Glenmark Pharmaceuticals Ltd, H1 2017
    Colorectal Cancer - Pipeline by Glycostem Therapeutics BV, H1 2017
    Colorectal Cancer - Pipeline by Glycotope GmbH, H1 2017
    Colorectal Cancer - Pipeline by Green Cross Corp, H1 2017
    Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H1 2017
    Colorectal Cancer - Pipeline by Handok Inc, H1 2017
    Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Heat Biologics Inc, H1 2017
    Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Humorigin Biotechnology Corp, H1 2017
    Colorectal Cancer - Pipeline by Hutchison China MediTech Ltd, H1 2017
    Colorectal Cancer - Pipeline by iDD biotech SAS, H1 2017
    Colorectal Cancer - Pipeline by Ideaya Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by Ignyta Inc, H1 2017
    Colorectal Cancer - Pipeline by Ildong Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd, H1 2017
    Colorectal Cancer - Pipeline by ImmuneXcite Inc, H1 2017
    Colorectal Cancer - Pipeline by Immunomedics Inc, H1 2017
    Colorectal Cancer - Pipeline by Immunovative Therapies Ltd, H1 2017
    Colorectal Cancer - Pipeline by Incanthera Ltd, H1 2017
    Colorectal Cancer - Pipeline by Incyte Corp, H1 2017
    Colorectal Cancer - Pipeline by Innovation Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Innovent Biologics Inc, H1 2017
    Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Interprotein Corp, H1 2017
    Colorectal Cancer - Pipeline by Intezyne Technologies Inc, H1 2017
    Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Isofol Medical AB, H1 2017
    Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by JHL Biotech Inc, H1 2017
    Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Johnson & Johnson, H1 2017
    Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Kancera AB, H1 2017
    Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Kura Oncology Inc, H1 2017
    Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A, H1 2017
    Colorectal Cancer - Pipeline by Lion Biotechnologies Inc, H1 2017
    Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc, H1 2017
    Colorectal Cancer - Pipeline by Lipopharma Therapeutics SL, H1 2017
    Colorectal Cancer - Pipeline by Loxo Oncology Inc, H1 2017
    Colorectal Cancer - Pipeline by Mabion SA, H1 2017
    Colorectal Cancer - Pipeline by MacroGenics Inc, H1 2017
    Colorectal Cancer - Pipeline by Mantis Therapeutics BV, H1 2017
    Colorectal Cancer - Pipeline by Marina Biotech Inc, H1 2017
    Colorectal Cancer - Pipeline by MediaPharma Srl, H1 2017
    Colorectal Cancer - Pipeline by MedImmune LLC, H1 2017
    Colorectal Cancer - Pipeline by Medinet Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Merck & Co Inc, H1 2017
    Colorectal Cancer - Pipeline by Merck KGaA, H1 2017
    Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Merus NV, H1 2017
    Colorectal Cancer - Pipeline by Microlin Bio Inc, H1 2017
    Colorectal Cancer - Pipeline by Molecular Partners AG, H1 2017
    Colorectal Cancer - Pipeline by MolMed SpA, H1 2017
    Colorectal Cancer - Pipeline by Mologen AG, H1 2017
    Colorectal Cancer - Pipeline by Morphotek Inc, H1 2017
    Colorectal Cancer - Pipeline by Multimmune GmbH, H1 2017
    Colorectal Cancer - Pipeline by Mycenax Biotech Inc, H1 2017
    Colorectal Cancer - Pipeline by NantKwest Inc, H1 2017
    Colorectal Cancer - Pipeline by Natco Pharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp, H1 2017
    Colorectal Cancer - Pipeline by Nektar Therapeutics, H1 2017
    Colorectal Cancer - Pipeline by Neovacs SA, H1 2017
    Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl, H1 2017
    Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by NormOxys Inc, H1 2017
    Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Novartis AG, H1 2017
    Colorectal Cancer - Pipeline by Novogen Ltd, H1 2017
    Colorectal Cancer - Pipeline by Noxxon Pharma AG, H1 2017
    Colorectal Cancer - Pipeline by NuCana BioMed Ltd, H1 2017
    Colorectal Cancer - Pipeline by OBI Pharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Omnitura Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Oncobiologics Inc, H1 2017
    Colorectal Cancer - Pipeline by Oncology Research International Ltd, H1 2017
    Colorectal Cancer - Pipeline by Oncolytics Biotech Inc, H1 2017
    Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Onconova Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Oryx GmbH & Co KG, H1 2017
    Colorectal Cancer - Pipeline by Otsuka Holdings Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Oxford BioMedica Plc, H1 2017
    Colorectal Cancer - Pipeline by Pfizer Inc, H1 2017
    Colorectal Cancer - Pipeline by Pharma Mar SA, H1 2017
    Colorectal Cancer - Pipeline by PharmAbcine Inc, H1 2017
    Colorectal Cancer - Pipeline by Pivotal BioSciences Inc, H1 2017
    Colorectal Cancer - Pipeline by PlantForm Corp, H1 2017
    Colorectal Cancer - Pipeline by Plexxikon Inc, H1 2017
    Colorectal Cancer - Pipeline by PLx Pharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Precision Biologics Inc, H1 2017
    Colorectal Cancer - Pipeline by Prima BioMed Ltd, H1 2017
    Colorectal Cancer - Pipeline by Propanac Biopharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Provectus Biopharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by PsiOxus Therapeutics Ltd, H1 2017
    Colorectal Cancer - Pipeline by Puma Biotechnology Inc, H1 2017
    Colorectal Cancer - Pipeline by Puretech Health plc, H1 2017
    Colorectal Cancer - Pipeline by Quintessence Biosciences Inc, H1 2017
    Colorectal Cancer - Pipeline by R Pharm, H1 2017
    Colorectal Cancer - Pipeline by Rafael Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by RedHill Biopharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by Redx Pharma Plc, H1 2017
    Colorectal Cancer - Pipeline by Rexahn Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Rgenix Inc, H1 2017
    Colorectal Cancer - Pipeline by Rhizen Pharmaceuticals SA, H1 2017
    Colorectal Cancer - Pipeline by Richter Gedeon Nyrt, H1 2017
    Colorectal Cancer - Pipeline by Samumed LLC, H1 2017
    Colorectal Cancer - Pipeline by Sanofi, H1 2017
    Colorectal Cancer - Pipeline by Selvita SA, H1 2017
    Colorectal Cancer - Pipeline by Siamab Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Sigma-Tau SpA, H1 2017
    Colorectal Cancer - Pipeline by Sigmoid Pharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by Sillajen Biotherapeutics, H1 2017
    Colorectal Cancer - Pipeline by Simcere Pharmaceutical Group, H1 2017
    Colorectal Cancer - Pipeline by Sorrento Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Steba Biotech SA, H1 2017
    Colorectal Cancer - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by SuviCa Inc, H1 2017
    Colorectal Cancer - Pipeline by Symphogen A/S, H1 2017
    Colorectal Cancer - Pipeline by SynDevRx Inc, H1 2017
    Colorectal Cancer - Pipeline by Synermore Biologics Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Taiho Pharmaceutical Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by TaiwanJ Pharmaceuticals Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
    Colorectal Cancer - Pipeline by Targovax ASA, H1 2017
    Colorectal Cancer - Pipeline by Tarrex Biopharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by Tiltan Pharma Ltd, H1 2017
    Colorectal Cancer - Pipeline by Tocagen Inc, H1 2017
    Colorectal Cancer - Pipeline by TRACON Pharmaceuticals Inc, H1 2017
    Colorectal Cancer - Pipeline by Transgene SA, H1 2017
    Colorectal Cancer - Pipeline by United BioPharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Vaccinex Inc, H1 2017
    Colorectal Cancer - Pipeline by VasGene Therapeutics Inc, H1 2017
    Colorectal Cancer - Pipeline by Vaximm AG, H1 2017
    Colorectal Cancer - Pipeline by ViiV Healthcare Ltd, H1 2017
    Colorectal Cancer - Pipeline by Vitality Biopharma Inc, H1 2017
    Colorectal Cancer - Pipeline by Wellstat Biologics Corp, H1 2017
    Colorectal Cancer - Pipeline by Wilex AG, H1 2017
    Colorectal Cancer - Pipeline by WntResearch AB, H1 2017
    Colorectal Cancer - Pipeline by Wuhan YZY Biopharma Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by XBiotech Inc, H1 2017
    Colorectal Cancer - Pipeline by XuanZhu Pharma Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Yabao Pharmaceutical Group Co Ltd, H1 2017
    Colorectal Cancer - Pipeline by Zymeworks Inc, H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..2) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..3) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..4) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..5) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..6) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..7) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..8) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..9) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..10) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..11) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..12) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..13) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..14) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..15) , H1 2017
    Colorectal Cancer - Dormant Projects, H1 2017 (Contd..16) , H1 2017
    Colorectal Cancer - Discontinued Products, H1 2017
    Colorectal Cancer - Discontinued Products, H1 2017 (Contd..1) , H1 2017
    Colorectal Cancer - Discontinued Products, H1 2017 (Contd..2) , H1 2017
    Colorectal Cancer - Discontinued Products, H1 2017 (Contd..3) , H1 2017
    Colorectal Cancer - Discontinued Products, H1 2017 (Contd..4) , H1 2017

    List of Figures

    Number of Products under Development for Colorectal Cancer, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Top 10 Routes of Administration, H1 2017
    Number of Products by Stage and Top 10 Routes of Administration, H1 2017
    Number of Products by Top 10 Molecule Types, H1 2017
    Number of Products by Stage and Top 10 Molecule Types, H1 2017
    2cureX ApS
    3-V Biosciences Inc
    3SBio Inc
    4SC AG
    AB Science SA
    AbbVie Inc
    AbGenomics International Inc
    Adamed Sp z oo
    Aduro BioTech Inc
    Advenchen Laboratories LLC
    Alchemia Ltd
    Allinky Biopharma
    amcure GmbH
    Amgen Inc
    Antibe Therapeutics Inc
    APEIRON Biologics AG
    Apexigen Inc
    Aphios Corp
    Aposense Ltd
    ARMO Biosciences Inc
    ArQule Inc
    Array BioPharma Inc
    Asana BioSciences LLC
    Aslan Pharmaceuticals Pte Ltd
    Astellas Pharma Inc
    Astex Pharmaceuticals Inc
    AstraZeneca Plc
    Aurobindo Pharma Ltd
    AVEO Pharmaceuticals Inc
    B Cell Design SAS
    Basilea Pharmaceutica Ltd
    Bavarian Nordic A/S
    Bayer AG
    BeiGene (Beijing) Co Ltd
    Beijing Hanmi Pharmaceutical Co Ltd
    BeyondSpring Pharmaceuticals Inc
    Biocon Ltd
    Bionomics Ltd
    Bionovis SA
    Biotecnol Ltd
    Biothera Pharmaceutical Inc
    Boehringer Ingelheim GmbH
    Boston Biomedical Inc
    Bristol-Myers Squibb Company
    Burzynski Research Institute Inc
    Calithera Biosciences Inc
    Cancer Prevention Pharmaceuticals Inc
    Carna Biosciences Inc
    Cascadian Therapeutics Inc
    CBT Pharmaceuticals Inc
    CCRP Therapeutics GmbH
    Celgene Corp
    Celldex Therapeutics Inc
    Cellectar Biosciences Inc
    Celleron Therapeutics Ltd
    Celltrion Inc
    Celyad SA
    Chipscreen Biosciences Ltd
    ChoDang Pharm Co Ltd
    Chong Kun Dang Pharmaceutical Corp
    Cipla Ltd
    Cleave Biosciences Inc
    Cleveland BioLabs Inc
    COARE Biotechnology Inc
    Coherus BioSciences Inc
    Compugen Ltd
    Conatus Pharmaceuticals Inc
    Confluence Life Sciences Inc
    Corvus Pharmaceuticals Inc
    Critical Outcome Technologies Inc
    CrystalGenomics Inc
    Daiichi Sankyo Company Ltd
    DanDrit Biotech A/S
    Deciphera Pharmaceuticals LLC
    Dicerna Pharmaceuticals Inc
    Dr. Reddy's Laboratories Ltd
    Eisai Co Ltd
    Eli Lilly and Company
    Endor Nanotechnologies SL
    EnGeneIC Ltd
    Ensol Biosciences Inc
    EntreChem SL
    Enzene Biosciences Ltd
    Enzo Biochem Inc
    EpiThany Inc
    Etubics Corp
    Exelixis Inc
    Exicure Inc
    F-star Biotechnology Ltd
    F. Hoffmann-La Roche Ltd
    Formosa Laboratories Inc
    Forty Seven Inc
    Fusion Antibodies Ltd
    Gene Techno Science Co Ltd
    Genentech Inc
    Genor BioPharma Co Ltd
    Genoscience Pharma
    Genzyme Corp
    Gilead Sciences Inc
    GlaxoSmithKline Plc
    Glenmark Pharmaceuticals Ltd
    Glycostem Therapeutics BV
    Glycotope GmbH
    Green Cross Corp
    Hadasit Medical Research Services & Development Ltd
    Handok Inc
    Hanmi Pharmaceuticals Co Ltd
    Heat Biologics Inc
    Hemispherx Biopharma Inc
    Humorigin Biotechnology Corp
    Hutchison China MediTech Ltd
    iDD biotech SAS
    Ideaya Biosciences Inc
    Ignyta Inc
    Ildong Pharmaceutical Co Ltd
    Immodulon Therapeutics Ltd
    ImmuneXcite Inc
    Immunomedics Inc
    Immunovative Therapies Ltd
    Incanthera Ltd
    Incyte Corp
    Innovation Pharmaceuticals Inc
    Innovent Biologics Inc
    Inovio Pharmaceuticals Inc
    Interprotein Corp
    Intezyne Technologies Inc
    Ionis Pharmaceuticals Inc
    Isofol Medical AB
    Jeil Pharmaceutical Co Ltd
    JHL Biotech Inc
    Jiangsu Hengrui Medicine Co Ltd
    Johnson & Johnson
    KaloBios Pharmaceuticals Inc
    Kancera AB
    Karyopharm Therapeutics Inc
    Kura Oncology Inc
    Laboratorio ELEA SACIF y A
    Lion Biotechnologies Inc
    LipoMedix Pharmaceutical Inc
    Lipopharma Therapeutics SL
    Loxo Oncology Inc
    Mabion SA
    MacroGenics Inc
    Mantis Therapeutics BV
    Marina Biotech Inc
    MediaPharma Srl
    MedImmune LLC
    Medinet Co Ltd
    Merck & Co Inc
    Merck KGaA
    Merrimack Pharmaceuticals Inc
    Merus NV
    Microlin Bio Inc
    Molecular Partners AG
    MolMed SpA
    Mologen AG
    Morphotek Inc
    Multimmune GmbH
    Mycenax Biotech Inc
    NantKwest Inc
    Natco Pharma Ltd
    NatureWise Biotech & Medicals Corp
    Nektar Therapeutics
    Neovacs SA
    Nerviano Medical Sciences Srl
    Nippon Kayaku Co Ltd
    NormOxys Inc
    Northwest Biotherapeutics Inc
    Novartis AG
    Novogen Ltd
    Noxxon Pharma AG
    NuCana BioMed Ltd
    OBI Pharma Inc
    Omnitura Therapeutics Inc
    Oncobiologics Inc
    Oncology Research International Ltd
    Oncolytics Biotech Inc
    OncoMed Pharmaceuticals Inc
    Onconova Therapeutics Inc
    Ono Pharmaceutical Co Ltd
    Oryx GmbH & Co KG
    Otsuka Holdings Co Ltd
    Oxford BioMedica Plc
    Pfizer Inc
    Pharma Mar SA
    PharmAbcine Inc
    Pivotal BioSciences Inc
    PlantForm Corp
    Plexxikon Inc
    PLx Pharma Inc
    Precision Biologics Inc
    Prima BioMed Ltd
    Propanac Biopharma Inc
    Provectus Biopharmaceuticals Inc
    PsiOxus Therapeutics Ltd
    Puma Biotechnology Inc
    Puretech Health plc
    Quintessence Biosciences Inc
    R Pharm
    Rafael Pharmaceuticals Inc
    RedHill Biopharma Ltd
    Redx Pharma Plc
    Rexahn Pharmaceuticals Inc
    Rgenix Inc
    Rhizen Pharmaceuticals SA
    Richter Gedeon Nyrt
    Samumed LLC
    Sanofi
    Selvita SA
    Siamab Therapeutics Inc
    Sichuan Kelun Pharmaceutical Co Ltd
    Sigma-Tau SpA
    Sigmoid Pharma Ltd
    Sillajen Biotherapeutics
    Simcere Pharmaceutical Group
    Sorrento Therapeutics Inc
    Steba Biotech SA
    Sumitomo Dainippon Pharma Co Ltd
    SuviCa Inc
    Symphogen A/S
    SynDevRx Inc
    Synermore Biologics Co Ltd
    Taiho Pharmaceutical Co Ltd
    TaiwanJ Pharmaceuticals Co Ltd
    Takeda Pharmaceutical Company Ltd
    Targovax ASA
    Tarrex Biopharma Ltd
    Tiltan Pharma Ltd
    Tocagen Inc
    TRACON Pharmaceuticals Inc
    Transgene SA
    United BioPharma Inc
    Vaccinex Inc
    VasGene Therapeutics Inc
    Vaximm AG
    ViiV Healthcare Ltd
    Vitality Biopharma Inc
    Wellstat Biologics Corp
    Wilex AG
    WntResearch AB
    Wuhan YZY Biopharma Co Ltd
    XBiotech Inc
    XuanZhu Pharma Co Ltd
    Yabao Pharmaceutical Group Co Ltd
    Zymeworks Inc

    Request for Sample

    Report Url https://www.reportsweb.com//colorectal-cancer-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//colorectal-cancer-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//colorectal-cancer-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments